What is the appropriate treatment for a 67-year-old male with Streptococcus agalactiae (group B streptococcus) isolated from urine culture?

Treatment of Group B Streptococcus (GBS) Bacteriuria in a 67-Year-Old Male

For a 67-year-old male with Group B Streptococcus isolated from urine culture, treat with penicillin or ampicillin as first-line therapy, as GBS remains universally susceptible to beta-lactams with proven efficacy and safety.

Antibiotic Selection

The choice of antibiotic should prioritize penicillin-based agents, as all available evidence confirms that GBS has maintained 100% susceptibility to penicillin and ampicillin 1, 2, 3. This is critical for both efficacy and antimicrobial stewardship.

First-Line Options:

• Penicillin G or Penicillin V: Remains the gold standard due to proven efficacy, narrow spectrum, and lack of resistance 4
• Ampicillin: 2 g IV every 4-6 hours (or oral equivalent if appropriate) 5, 4
• Amoxicillin: Oral alternative for outpatient management

Alternative Agents (for penicillin allergy):

• Ceftriaxone: 1-2 g IV/IM once daily - highly effective for non-anaphylactic penicillin allergies 4
• Cefazolin: 1 g IV every 8 hours 4
• Vancomycin: 1 g IV every 12 hours - reserved only for patients with true anaphylactic penicillin allergy 5

Critical Consideration: Fluoroquinolone Resistance

Avoid fluoroquinolones as empiric therapy. Recent data shows concerning fluoroquinolone resistance rates of 12.8-22.5% in GBS urinary isolates, particularly in males 2, 3. This represents a significant departure from historical susceptibility patterns and makes quinolones unreliable for GBS UTIs.

Treatment Duration and Clinical Context

The treatment approach depends on whether this represents:

Asymptomatic Bacteriuria (No Treatment Needed):

• If the patient has no urinary symptoms (dysuria, frequency, urgency, suprapubic pain, fever), this likely represents colonization
• Do not treat asymptomatic bacteriuria in non-pregnant adults 6
• Exception: Treat if undergoing urologic procedures 7

Symptomatic UTI (Requires Treatment):

• Uncomplicated cystitis: 7-10 days of oral therapy
• Complicated UTI (with diabetes, immunosuppression, or anatomic abnormalities): 10-14 days 2
• Pyelonephritis or upper tract involvement: 14 days minimum with IV therapy initially 8

Risk Stratification

This 67-year-old male warrants careful evaluation for:

1. Underlying comorbidities: GBS UTIs in males are strongly associated with diabetes mellitus 2
2. Anatomic abnormalities: Prostatic disease, urinary retention, or stones increase risk
3. Immunosuppression: Requires longer treatment duration
4. Signs of invasive disease: Fever, bacteremia, or endocarditis risk 4

If any complicated features are present, initiate IV ampicillin 2 g every 4-6 hours and consider infectious disease consultation 4.

Common Pitfalls to Avoid

• Do not use trimethoprim-sulfamethoxazole as first-line: While one case report describes its use 9, there is no guideline support and susceptibility data is limited
• Do not reflexively treat asymptomatic bacteriuria: This leads to unnecessary antibiotic exposure 6
• Do not assume all gram-positive cocci are enterococci: GBS requires different treatment considerations than enterococcal UTIs
• Do not use clindamycin or erythromycin: Resistance rates of 5-24% make these unreliable 1, 3

Monitoring and Follow-Up

• Clinical improvement should occur within 48-72 hours of appropriate therapy
• Repeat urine culture is not routinely needed if symptoms resolve 6
• Investigate for urologic abnormalities if recurrent GBS UTIs occur, as this is uncommon in males without underlying pathology 2
• Screen for diabetes mellitus if not previously diagnosed, as this is a major risk factor 2